GYNARICH INJ

215.00

Estimate Delivery: Sorry, we are unable to get the delivery time at the moment.
43215, Columbus
The delivery date will depend on the items in the cart.
Offers and Coupons
Check Coupons
Offers and Coupons
Use coupon BLACKFRIDAY Extra 10% off
BlackFriday Sale
Use coupon NEWUSER Extra 5% off
Welcome Offer! Use code NEWUSER to enjoy an additional 5% discount on your first purchase. (T&C Apply)
  • COD available for orders between 800-4,000
  • Free Delivery on orders 1,000 and above!
Buy Now
Add to wishlist

Ingredients
Buserelin Acetate: As the main active ingredient, Buserelin Acetate is a synthetic analogue of gonadotropin-releasing hormone (GnRH). It is instrumental in altering hormone levels to treat conditions like prostate cancer in males and aid in breeding management in females, especially in horses. By mimicking natural hormones, it facilitates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), playing a key role in reproductive health.

Key Features
Versatility: Suitable for a wide range of animals, including domestic pets and farm animals.
Quality Assurance: Manufactured by INTAS, a leader in veterinary products.
Effective Reproductive Management: Especially beneficial in managing breeding cycles in horses.

Uses and Benefits
GYNARICH INJ is pivotal in managing reproductive health. For male animals, it aids in the treatment of hormone-dependent conditions like prostate cancer by reducing testosterone levels. In female animals, particularly mares, it is used to regulate estrous cycles, aiding in breeding efficiency.

Directions for Use
GYNARICH INJ should be administered by a qualified veterinarian. Dosage varies based on the animal and the condition being treated, underscoring the importance of professional guidance.

Precautions
Consultation with a veterinarian is vital before administering GYNARICH INJ. The product should be used with caution in animals with known hypersensitivity to its components.

Reviews

There are no reviews yet

Add a review
Currently, we are not accepting new reviews